Computational Identification of Inhibitors of Protein-Protein Interactions
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
The ability to control protein-protein interactions (PPIs) for therapeutic purposes is attractive since many processes in cells involve such interactions. Recent successes in the discovery of small molecules that target protein-protein interactions for drug development have shown that targeting these interactions is indeed feasible. In the present review the use of computer-aided drug design (CADD) via database screening or docking algorithms for identifying inhibitors of protein-protein interactions is introduced. The principles of database screening and a practical protocol for targeting PPIs are described. The recent applications of these approaches to different systems involving protein-protein interactions, including BCL-2, S100B, ERK and p56lck, are presented and provide valuable examples of inhibitor discovery and design.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Friesner, R. A., Banks, J. L., Murphy, R. B., Halgren, T. A., Klicic, J. J., Mainz, D. T., Repasky, M. P., Knoll, E. H., Shelley, M., Perry, J. K., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0306430 · Cited by 10,057
The Amber biomolecular simulation programs
Case, D. A., Cheatham, T. E., Darden, T., Gohlke, H., Luo, R., Merz, K. M., Onufriev, A., Simmerling, C., Wang, B., & Woods, R. J. (2005) · Journal of Computational Chemistry · doi:10.1002/jcc.20290 · Cited by 9,535 · cited 2×
“Partial atomic charges are historically those from AMBER [143] or from the method of Gasteiger [240].”
MethodMolecular properties that influence the oral bioavailability of drug candidates
Veber, D. F., Johnson, S. R., Cheng, H.-Y., Smith, B. R., Ward, K. W., & Kopple, K. D. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020017n · Cited by 8,420 · cited 1×
“This empirical rule has been further developed [251] and recently reviewed [252] and alternate rules based on polar surface area and number of rotatable bonds have been presented [253].”
BackgroundDevelopment and validation of a genetic algorithm for flexible docking 1 1Edited by F. E. Cohen
Jones, G., Willett, P., Glen, R. C., Leach, A. R., & Taylor, R. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1996.0897 · Cited by 6,763 · cited 7×
“…[92], DOCK [81], DockVision [93], DOT [94], ECEPP/3 [95], FDS [96], FlexX [97], GAPDOCK [98], GasDock [99], GEMDOCK [100], Glide [101] [102], GOLD [103], GRAMM [104], HADDOCK [105], ICM-DISCO [106], ICM-Dock [107], IFREDA [108], LibDock [109], LIGPLOT [110], LigandFit [111], PatchDock and…”
BackgroundMethodInfluentialHandbook of Molecular Descriptors
Todeschini, R., & Consonni, V. (2000) · Methods and Principles in Medicinal Chemistry · doi:10.1002/9783527613106 · Cited by 4,107 · cited 2×
“The information in SDF files may act as the starting point for the generation of 3D structures followed by for further geometry optimization [16] and are used in several database searching algorithms based on 2D molecular descriptors [237].”
BackgroundMethodZINC − A Free Database of Commercially Available Compounds for Virtual Screening
Irwin, J. J., & Shoichet, B. K. (2005) · Journal of Chemical Information and Modeling · doi:10.1021/ci049714+ · Cited by 4,058 · cited 3×
“An alternative are 3D databases in which a large number of conformations of each compounds are stored [225].”
BackgroundHADDOCK: A Protein−Protein Docking Approach Based on Biochemical or Biophysical Information
Dominguez, C., Boelens, R., & Bonvin, A. M. J. J. (2003) · Journal of the American Chemical Society · doi:10.1021/ja026939x · Cited by 3,187 · cited 2×
“These include 3D-Dock Suite (FTDock [83], RPScore [84] and MultiDock [85]), Affinity (Insight II), AutoDock [86], BiGGER [87], CDOCKER [88], ChemScore [89], ClusPro [90], COMBINE [91], CONCOORD/DISCO [92], DOCK [81], DockVision [93], DOT [94], ECEPP/3 [95], FDS [96], FlexX [97], GAPDOCK [98], GasDock [99], GEMDOCK [10…”
MethodPatchDock and SymmDock: servers for rigid and symmetric docking
Schneidman-Duhovny, D., Inbar, Y., Nussinov, R., & Wolfson, H. J. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki481 · Cited by 3,018 · cited 2×
“These include 3D-Dock Suite (FTDock [83], RPScore [84] and MultiDock [85]), Affinity (Insight II), AutoDock [86], BiGGER [87], CDOCKER [88], ChemScore [89], ClusPro [90], COMBINE [91], CONCOORD/DISCO [92], DOCK [81], DockVision [93], DOT [94], ECEPP/3 [95], FDS [96], FlexX [97], GAPDOCK [98], GasDock [99], GEMDOCK [10…”
Anatomy of hot spots in protein interfaces
Bogan, A. A., & Thorn, K. S. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.1843 · Cited by 1,988
Small-molecule inhibitors of protein–protein interactions: progressing towards the dream
Arkin, M. R., & Wells, J. A. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1343 · Cited by 1,705
ZDOCK: An initial‐stage protein‐docking algorithm
Chen, R., Li, L., & Weng, Z. (2003) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.10389 · Cited by 1,393
Principles of docking: An overview of search algorithms and a guide to scoring functions
Halperin, I., Ma, B., Wolfson, H., & Nussinov, R. (2002) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.10115 · Cited by 1,294 · cited 1×
“A number of recent reviews address the various docking methodologies and their applications [17] [21] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62].”
The PDBbind database: methodologies and updates
Wang, R., Fang, X., Lu, Y., Yang, C.-Y., & Wang, S. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm048957q · Cited by 933 · cited 1×
“PDBbind database [230] (http://www. pdbbind.org/) provides a comprehensive collection of binding affinities for the protein-ligand complexes in the Protein Data Bank (PDB).”
BackgroundComparative evaluation of 11 scoring functions for molecular docking.
Wang, R., Lu, Y., & Wang, S. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm0203783 · Cited by 849 · cited 2×
“Wang and co-workers presented a comparative evaluation of 11 scoring functions [124] and pointed out that some scoring functions including PLP, F-Score, LigScore, DrugScore, LUDI, and X-Score, yield higher hit-rates.”
BackgroundMethodStructural biology of the Bcl-2 family of proteins
Petros, A. M., Olejniczak, E. T., & Fesik, S. W. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2003.08.012 · Cited by 745 · cited 1×
“2A) [263].”
Bissantz, C., Folkers, G., & Rognan, D. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm001044l · Cited by 740 · cited 1×
“In most docking tools, these scoring functions can be used in combined ways, such as consensus scoring [217] [218] [219] [220].”
MethodCAPRI: A Critical Assessment of PRedicted Interactions
Janin, J., Henrick, K., Moult, J., Eyck, L. T., Sternberg, M. J. E., Vajda, S., Vakser, I., & Wodak, S. J. (2003) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.10381 · Cited by 703
Charifson, P. S., Corkery, J. J., Murcko, M. A., & Walters, W. P. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm990352k · Cited by 698
Atomic structure of the MAP kinase ERK2 at 2.3 A resolution
Zhang, F., Strand, A., Robbins, D., Cobb, M. H., & Goldsmith, E. J. (1994) · Nature · doi:10.1038/367704a0 · Cited by 592 · cited 16×
“In vitro, dozens of proteins can be phosphorylated by ERK.”
BackgroundMethodInfluential
Cited by
Computer-Aided Drug Design Methods
Yu, W., & MacKerell, A. D. (2017) · Methods in Molecular Biology · doi:10.1007/978-1-4939-6634-9_5 · Cited by 583
Self-citationAcharya, C., Coop, A., E. Polli, J., & D. MacKerell, A. (2011) · Current Computer Aided-Drug Design · doi:10.2174/157340911793743547 · Cited by 340
Predicting druggable binding sites at the protein–protein interface
Fuller, J. C., Burgoyne, N. J., & Jackson, R. M. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2008.10.009 · Cited by 310
A Small-Molecule Inhibitor of BCL6 Kills DLBCL Cells In Vitro and In Vivo
Cerchietti, L. C., Ghetu, A. F., Zhu, X., Da Silva, G. F., Zhong, S., Matthews, M., Bunting, K. L., Polo, J. M., Farès, C., Arrowsmith, C. H., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.050 · Cited by 288
“…the last decade small-molecule inhibitors have been identified for an increasing number of protein-protein interactions (Wells and McClendon, 2007; Zhong et al., 2007), including ERK kinase (Hancock et al., 2005), S100B-p53 (Markowitz et al., 2004), eIF4E-eIF4G translation initiation factors…”
BackgroundSelf-citationTargeting Protein–Protein Interactions for Therapeutic Intervention: A Challenge for the Future
Zinzalla, G., & Thurston, D. E. (2009) · Future Medicinal Chemistry · doi:10.4155/fmc.09.12 · Cited by 260
Metadata
- Authors
- Zhong, S., Macias, A., & MacKerell, A.
- Venue
- Current Topics in Medicinal Chemistry
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2007-01-01
- Volume
- 7
- Issue
- 1
- Pages
- 63-82
- ISSN
- 1568-0266 (ISSN-L)
- OpenAlex
- W1980549837
- Cited by
- 84
- References
- 19
- FWCI
- 11.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.